GRI Bio GRI Income Statement (2020-2026)

NASDAQ GRI
$2.00 -0.10 (-4.76%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

GRI Bio Quarterly Income Statement

Periods 26 quarters
Latest Jun 2026

GRI Bio reported net income of -$1.65M for the quarter ended Jun 2026. This income statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity)Shares Outstanding (Entity.)
0.00M0.00M0.00M0.01M0.01M0.01M290.000.00M0.00M0.00M0.02M0.03M0.19M0.18M0.53M2.50M2.62M0.10M1.24M1.80M
Revenue & cost
Revenue
Operating items
Research & DevelopmentR&D
0.21M2.00M1.27M0.06M0.06M0.06M0.12M0.88M1.19M1.05M0.93M0.88M1.12M0.91M1.64M1.88M1.77M1.63M0.36M0.41M
Selling, General & AdministrativeSG&A
1.04M1.10M1.36M0.13M0.12M1.61M0.87M5.05M1.25M0.98M0.96M1.38M1.00M1.05M1.41M1.02M1.60M1.03M1.64M1.24M
Operating ExpensesOpex
1.25M3.09M2.63M0.19M0.19M1.67M0.99M5.93M2.44M2.03M1.90M2.26M2.13M1.95M3.05M2.90M3.37M2.66M2.00M1.65M
Operating IncomeOp. Inc
-1.25M-3.09M-2.63M-0.19M-0.19M-1.67M-0.99M-5.93M-2.44M-2.03M-1.90M-2.26M-2.13M-1.95M-3.05M-2.90M-3.37M-2.66M-2.00M-1.65M
EBIT
-1.25M-3.09M-2.63M-0.19M-0.19M-1.67M-0.99M-5.93M-2.44M-2.03M-1.90M-2.26M-2.13M-1.95M-3.05M-2.90M-3.37M-2.66M-2.00M-1.65M
Non-operating items
Non Operating Investment Income
-0.00M0.00M
Other Non Operating IncomeOther Non Op Inc.
-0.33M0.12M0.25M0.00M0.00M
Net income details
EBT
-1.25M-3.09M-2.63M-0.19M-0.19M-1.67M-0.99M-5.93M-2.44M-2.03M-1.90M-2.26M-2.13M-1.95M-3.05M-2.90M-3.37M-2.66M-2.00M-1.65M
Profit After TaxPAT
-1.25M-3.09M-2.63M-0.19M-0.19M-1.67M-0.99M-5.93M-2.44M-2.03M-1.90M-2.26M-2.13M-1.95M-3.05M-2.90M-3.37M-2.66M-2.00M-1.65M
Income from Continuing OperationsIncome (Continuing)
-1.25M-3.09M-2.63M-0.19M-0.19M-1.67M-0.99M-5.93M-2.44M-2.03M-1.90M-2.26M-2.13M-1.95M-3.05M-2.90M-3.37M-2.66M-2.00M-1.65M
Consolidated Net IncomeConsol Net Inc.
-1.25M-3.09M-2.63M-0.19M-0.19M-1.67M-0.99M-5.93M-2.44M-2.03M-1.90M-2.26M-2.13M-1.95M-3.05M-2.90M-3.37M-2.66M-2.00M-1.65M
Income towards Parent CompanyParent Net Inc
-1.26M-3.10M-0.30M-0.29M-0.35M-2.27M-2.15M-6.75M-2.14M-2.00M-1.89M-2.25M-2.12M-1.95M-3.05M-2.89M-3.36M-2.66M-2.00M-1.64M
Net Income towards Common StockholdersNet Income
-1.26M-3.10M-0.30M-0.29M-0.35M-2.27M-2.15M-6.75M-2.14M-2.00M-1.89M-2.25M-2.12M-1.95M-3.05M-2.89M-3.36M-2.66M-2.00M-1.64M
Additional items
EPS (Basic)
-285.42-732.26-68.57-52.57-44.86-346.10-0.01M-0.00M-801.58-959.77-101.05-83.57-11.42-10.63-5.80-1.31-1.28-27.09-1.61-0.91
EPS (Diluted)
-285.42-732.26-68.57-52.57-44.86-346.10-0.01M-0.00M-801.58-959.77-101.05-83.57-11.42-10.63-5.80-1.31-1.28-27.09-1.61-0.91
Shares Outstanding
0.00M0.00M0.00M0.01M0.01M0.01M290.000.00M0.00M0.00M0.02M0.03M0.19M0.18M0.53M2.21M2.62M0.10M1.24M1.80M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
0.00M0.00M0.00M0.01M0.01M0.01M290.000.00M0.00M0.00M0.02M0.03M0.19M0.18M0.53M2.21M2.62M0.10M1.24M1.80M
EBITDA
-1.23M-3.08M-2.62M-0.21M-0.18M-1.67M-0.99M-5.93M-2.44M-2.02M-1.89M-2.26M-2.13M-1.95M-3.05M-2.90M-3.36M-2.66M-2.00M-1.65M

GRI Bio Income Statement API

Pull GRI Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=GRI&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY